Behavioral Risk Factor Surveillance Survey, 58n

Bias, 47, 52, 56-57, 158, 204

selection, 56, 188

Biologic and chemical warfare

agents for, 71

threat of, 14-15

vaccination against, 67

Biologic monitoring, 39-41

depleted uranium, 39-40

oil-well fire smoke, 40-41

Bipolar disorder, 122

Birth defects and adverse pregnancy outcomes (ICD-10 O00-Q99), 3, 6, 192-195, 248, 252

adverse pregnancy outcomes, 194-195

birth defects, 192-195

continued surveillance for, 8, 254

Goldenhar syndrome, 194

male fertility problems and infertility, 196

primary studies, 192-193

secondary studies, 193-194

spontaneous abortion, 252

summary and conclusion, 194

Brain cancer, 5, 116, 118, 251

continued surveillance for, 8, 254

Brief Symptom Inventory (BSI), 58n, 76, 125

Bronchitis, 64, 170-175

BSI. See Brief Symptom Inventory

C

CAGE questionnaire, 58n, 123

Canadian Veteran Study, 65, 125, 163, 171, 189, 194, 228, 250

exposure-symptom relationships, 65

symptom clustering, 65

Cancer (ICD-10 C00-D48), 5, 115-121

all cancers, 117-118, 120-121

brain cancer, 116, 119

continued surveillance for, 8, 254

primary and secondary studies, 116-118

summary and conclusion, 118

testicular cancer, 116-117, 119-120

CAPS. See Clinician-Administered PTSD Scale

Carbon monoxide (CO) exposure, 26

Cardiovascular disease, 6, 166-169, 252

primary studies, 166-167

secondary studies, 167-168

summary and conclusion, 168

Front Matter (R1-R16)

Summary (1-10)

1 Introduction (11-20)

2 Exposures in the Persian Gulf (21-44)

3 Considerations in Identifying and Evaluating the Literature (45-54)

4 Major Cohort Studies (55-114)

5 Health Outcomes (115-246)

6 Conclusions and Recommendations (247-260)

Index (261-276)